Stempeutics Research, a stem cell research company from India's southern city of Bangalore, could launch the country's first-ever therapy using adult stem cells to treat heart attack in next two years, reports said.

Stem Cell Therapeutics Corp has received final approval to begin patient studies using its new stem cell therapy NTx-265 for ischemic stroke, the company announced.

A new technology to reprogramme human cells into various cells developed by Fate Therapeutics has been granted patent in US.

NTx-265, a new therapy regimen to stimaulate patients' own stem cells to deal with severe traumatic brain injury by Stem Cell Therapeutics Corp has been given a No Objection Letter (NOL) by Health Canada.

The leading players in this five-year-old in the stem cell banking industry in India are:

Banking life saving umbilical cord blood of your child will offer a potential resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders.

IND 13729, a stem cell therapy for the treatment of amyotrophic lateral sclerosis (ALS), has been given approval for first-in-man studies.

ReN001 stem-cell line, a experimental therapy that offers great promise to rejuvenate brain cells in stroke patients developed by ReNeuron, has been approved for clinical studies by UK government.